From Ireland to Global Markets: The Funding Behind Active Iron’s Expansion

Solvotrin Therapeutics is an Irish healthcare development company that enhances established therapies through innovative, patent-protected science and  bringing them to market. Solvotrin has developed and successfully commercialised Active Iron, an innovative oral iron product, establishing a growing global distribution network, and a presence in circa. 20 global markets. As Active Iron expands across new geographies, Solvotrin partnered with Financefair to put in place a working capital solution that could fund that growth without slowing it down.

Active Iron is a novel, patent-protected iron complex, clinically proven to increase iron levels while uniquely avoiding the common side effects that limit most oral iron₁. This clinical evidence is the foundation of healthcare professional recommendation and product differentiator. Active Iron has secured shelf space in some of the world’s most competitive pharmacy, healthcare and retail channels — giving consumers an effective and gentle way to support energy, wellbeing and everyday performance.

Active Iron is sold across Ireland and the UK through major retail partners including Boots, Holland & Barrett and Sainsbury’s, on Amazon, and through a growing global distributor network spanning Europe, North America, the Middle East and Asia Pacific. In the United States, the brand has also established itself in the prestigious practitioner channel, where it is recommended by doctors. With regulatory approvals secured across multiple jurisdictions, Active Iron continues to expand into new markets.